The Latest Breaking News from Covid-19

PRAYAGRAJ: As normalcy bounces back after the deadly waves of Covid pandemic, North Central Railway (NCR) has recorded an impressive improvement in total parcel earning in the month of June 2022. NCR has notched up a tentative total parcel earning of an impressive Rs 2.26 crore.

MUMBAI: A new subvariant of Omicron, BA.2.75, has been identified in ten Covid patients in Pune. This second-generation subvariant of BA.2 is said to have a growth advantage over other sublineages, but its impact will be known in the coming weeks, experts said.

A fourth dose of the vaccine is recommended for people over 50 and offered to all people 30 and older, as the country faces a winter jump in COVID hospitalisations.

“Beauty is an iron mine,” once remarked the Australian mining magnate, Gina Reinhart. She was talking about a precious resource, but iron is also profoundly important to living organisms: from bacteria and fungi, to mammals like us.

Macau locks down one of the city's most famous hotels, the Grand Lisboa, as COVID-19 infections spread rapidly in the world's biggest gambling hub.

It's not an easy time to be on the show circuit with increased fuel prices, insurance bills, extreme floods and a lingering pandemic. So, how are ag shows going?

As viruses morph and adapt, there's a greater call for targeted vaccines and boosters

While non-Hispanic white people accounted for nearly two-thirds of all deaths nationwide, the non-Hispanic Native American and Black populations died at disproportionately higher rates.

Toshiba (Thailand) Co, the distributor of Toshiba home appliances, expects double-digit sales growth for the third consecutive year in 2022, bolstered by easing of Covid-19 control measures and the country's full reopening to foreign tourists.

Baidu Inc (NASDAQ: BIDU) shares are trading lower by 5.41% to $145.91 Wednesday morning. Shares of Chinese companies at large are trading lower after Shanghai announced it will be conducting mass COVID-19 testing in several districts following a rise in cases.

Veru Inc (NASDAQ: VERU) shares are trading higher Wednesday after the company announced the publication of the results from a Phase 3 COVID-19 study evaluating the efficacy and safety of oral sabizabulin for the treatment of hospitalized moderate-severe COVID-19 patients at high risk for acute res